Home > Boards > US Listed > Biotechs > Verastem (VSTM)

2.17$ actually, how deep?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
doky69 Member Profile
 
Followed By 0
Posts 22
Boards Moderated 0
Alias Born 03/17/12
160x600 placeholder
Verastem Oncology Announces Dosing of First Patient in Yakult Honsha Co., Ltd.’s Japanese Bridging Study Evaluating COPIKTR... Business Wire - 10/7/2019 7:00:00 AM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 10/4/2019 7:00:00 AM
Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma Business Wire - 10/3/2019 2:25:00 PM
Verastem Oncology Presents New Preclinical Duvelisib Data at the 5th International Conference on New Concepts in Lymphoid Mal... Business Wire - 10/3/2019 7:00:00 AM
Verastem Oncology to Present at the Cantor 2019 Global Healthcare Conference Business Wire - 9/26/2019 7:00:00 AM
Verastem Oncology Announces COPIKTRA™ (Duvelisib) Presentations at the 18th Annual International Workshop on Chronic Lympho... Business Wire - 9/20/2019 1:00:00 PM
Verastem Oncology to Present at the 21st Annual H.C. Wainwright Global Investment Conference Business Wire - 9/3/2019 4:05:00 PM
Verastem Oncology Announces COPIKTRA™ (Duvelisib) Presentations at the Society of Hematologic Oncology 2019 Annual Meeting Business Wire - 9/3/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 5:09:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 4:06:59 PM
Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress Business Wire - 8/1/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2019 7:43:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 4:17:25 PM
Verastem Oncology Appoints Brian Stuglik as Chief Executive Officer Business Wire - 7/29/2019 4:05:00 PM
Verastem in Licensing Agreement with Sanofi; Shares Up Dow Jones News - 7/25/2019 5:31:00 PM
Verastem Oncology Signs an Exclusive License Agreement with Sanofi for the Development & Commercialization of COPIKTRA® (duv... Business Wire - 7/25/2019 4:05:00 PM
Verastem Oncology to Announce Second Quarter 2019 Financial Results and Corporate Update on August 1, 2019 Business Wire - 7/25/2019 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2019 4:29:18 PM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 7/3/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:12:40 PM
Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data in Peripheral T-Cell Lymphoma at the 2019 International Conference on... Business Wire - 6/21/2019 7:00:00 AM
Verastem Oncology Announces Leadership Changes Business Wire - 6/20/2019 7:00:00 AM
Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data at the European Hematology Association 2019 Annual Meeting Business Wire - 6/17/2019 7:00:00 AM
Verastem Oncology to Present at the Jefferies 2019 Global Healthcare Conference Business Wire - 5/30/2019 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/20/2019 5:23:17 PM
doky69   Wednesday, 04/17/19 10:09:49 AM
Re: None
Post # of 464 
2.17$ actually, how deep?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist